Mike is responsible for overseeing operational strategies at FIECON, ensuring first-class deliverables and client satisfaction. With more than a decade of experience in market access and pricing, Mike has worked with leading global pharmaceutical companies on key access-based projects. His previous roles include senior positions at Covance Market Access and working as a Research Scientist, contributing significantly to pharmaceutical strategy.
Mike holds a BSc in Biochemistry from the University of Birmingham and a PhD in Molecular Biochemistry from the University of Southampton.
Led global strategic and tactical projects for pharmaceutical, biotech, and medical device companies.
Experience with leading pharmaceutical companies
Worked on access and launch strategies for seven of the top ten global pharmaceutical companies.
Senior leadership in market access
Developed pricing, landscape assessments, and economic modelling solutions for major healthcare clients.
Experience in range of therapy areas:
Multiple sclerosis, Alzheimer’s
Diabetes, Autoimmune disease
Respiratory disease
Cardiovascular
Orphan/ultra-orphan conditions
Women’s health
Ophthalmology
Infectious disease
Oncology
Medical devices, diagnostics
FIECON exceeds my expectations by genuinely trying to achieve the best outcomes for our company. Their flexibility to adapt to unexpected changes and apply technical rigour, while respecting the commercial focus of the company is unparalleled. We see FIECON as part of our extended team.”
Senior Market Access Manager, Mid-sized Pharma
It was brilliantly smart and very well explained. It seems obvious now but that is what genius is, making complex things appear simple.”
Associate Director, Mid-sized Pharma
FIECON are my go to trusted partner. The team deliver high-quality work to timeline, every time. But more than this, FIECON has worked as part of our team, working towards achieving the best possible outcome by providing high level strategic input and challenge during our discussions.”
Market Access Director, Small Biotech
FIECON’s highly skilled expert team helped us to successfully tackle a number of tough pricing and access challenges. Apart from their flawless technical expertise, we have a reliable thought partner to pressure test new ideas and strategies that have a broader relevance than purely health economic aspects.”
Disease Area Director, Big Pharma
The pricing and market access research was a high quality work project, which included detailed information to define the overall and country strategy while the gap analysis was instrumental in the next steps preparation. ”
Executive Director, Biotech
FIECON’s strategic approach to problem solving is a breath of fresh air. We highly value their HTA knowledge and expertise, and they consistently deliver the best solution for us.”
Value Demonstration & Access Lead, Big Pharma
It is a pleasure to work with FIECON. The team are passionate about what they do and it really shows in their high-quality, creative solutions. Working with FIECON gives your projects the highest chance of success.”
Senior Vice President, Small Biotech
FIECON’s team is highly experienced, commercially focused, responsive and flexible. A particular strength I highlight is that FIECON’s team becomes a true partner with all company functions that they interact with. ”
